DSCAM and cancer: This phenomenon may be explained by a requisite genetic and epigenetic milieu provided by ER-positive cells in order for DSCAM-AS1 to confer its cancer phenotype, and more investigation into the precise mechanisms through which it acts will shed light on this finding.